TickerFactsScreenerDevelopers

Regen BioPharma Inc (RGBP) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2012: $9232013: $116.0K2016: $24.8K2017: $270.0K2018: $8.0K2019: $7.9K2020: $02021: $727.2K2022: $51.2K2023: $121.0K2024: $7162025: $69.6K$69.6K
2012Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$69.6K+9614.4%
2024$716-99.4%
2023$121.0K+136.4%
2022$51.2K-93.0%
2021$727.2K—
2020$0-100.0%
2019$7.9K-2.0%
2018$8.0K-97.0%
2017$270.0K+987.6%
2016$24.8K—
2013$116.0K+12466.8%
2012$923—